Tag: GARDP
Novel broad-spectrum antibiotic compound prioritized for development in fight against AMR
Under the agreement, GARDP will provide up to US$20 million to Bugworks in technical and financial support for the pharmaceutical and clinical co-development of BWC0977
GARDP supports Bugworks in assessing safety of new antibiotic compound
The support of the cardiac safety study follows a memorandum of understanding signed by GARDP and Bugworks in August 2020 to accelerate the development and availability of antibiotic treatments
Drug resistance posing new challenge to child survival
Given the rise in bacteria resistance to existing treatments, hospitalized newborns and infants are at high risk of developing drug-resistant hospital-acquired infection...……….